Global Lithotripsy Devices Market Size study, by Type, by Application, by End-use and Regional Forecasts 2022-2032

Global Lithotripsy Devices Market was valued at approximately USD 1.28 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 6.40% over the forecast period 2024-2032. Lithotripsy is a medical procedure utilized for breaking down kidney stones and stones in other organs such as the gallbladder or liver, making it easier for them to pass out of the body. This treatment is particularly crucial when large stones cause severe pain, bleeding, or urinary tract infections. The most prevalent method, extracorporeal shock wave lithotripsy, leverages sound waves to fragment large kidney stones into smaller pieces. Although not all kidney stones are treatable with this method, its safety, cost-efficiency, and minimal recovery time make it highly preferred. Intracorporeal lithotripsy, on the other hand, can treat all compositions of kidney stones and boasts a high success rate for ureteral stones without significant complications.

The increasing prevalence of kidney stones is the primary driver for the Lithotripsy Device Market. Over the years, lithotripsy has emerged as the favored treatment method for kidney stones due to its safety, affordability, quick recovery time, and favorable patient outcomes. Furthermore, intracorporeal lithotripsy devices can effectively treat all types of kidney stones and achieve high success rates for ureteral stones without major complications. However, the market growth is impeded by a lack of innovation and limited industry interest in funding emerging technologies. Also, growing awareness about kidney stone management and improved healthcare infrastructure in developing regions are expected to enhance accessibility to lithotripsy procedures, thus boosting demand for lithotripsy devices. Favorable reimbursement policies and insurance coverage for these procedures have further encouraged patients to seek treatment, supporting market expansion. Continuous research and development in medical devices are leading to technological advancements in lithotripsy devices, making them safer, more effective, and user-friendly. Healthcare providers are eager to adopt these advanced technologies, further driving market growth. Additionally, efforts to educate patients and physicians about kidney stones and treatment options are likely to positively impact the demand for lithotripsy devices. Improved awareness may lead to early diagnosis and more frequent use of lithotripsy as the preferred treatment option. Also, the trend towards ambulatory care and same-day procedures is growing due to cost-effectiveness and patient convenience. Since lithotripsy procedures can often be performed in outpatient settings, the expansion of ambulatory surgical centers is expected to fuel the adoption of lithotripsy devices. Moreover, the incorporation of remote monitoring technologies and telemedicine can enhance post-operative care, potentially leading to better outcomes and greater acceptance of lithotripsy procedures.

North America held the largest market share of 31.2% in 2023. The lithotripsy devices market in North America is poised to expand due to the rising prevalence of kidney stones, technological advancements, and a preference for minimally invasive treatments. Additionally, well-established healthcare infrastructure, increased healthcare expenditure, an aging population, reimbursement support, and market competitiveness contribute to the region's growth. Asia Pacific is anticipated to grow at the fastest rate during the forecast period, driven by a large patient pool and rising incidence of kidney stones. Improved healthcare infrastructure and the region's status as a medical tourism destination are also key factors enhancing demand for lithotripsy devices.

Major market player included in this report are:

• Medtronic plc
• Boston Scientific Corporation
• Olympus Corporation
• Siemens Healthineers AG
• Dornier MedTech GmbH
• Karl Storz SE & Co. KG
• Richard Wolf GmbH
• Stryker Corporation
• EDAP TMS S.A.
• Cook Medical LLC
• Lumenis Ltd.
• Shockwave Medical Inc.
• EMS Electro Medical Systems S.A.
• DirexGroup
• MTS Medical

The detailed segments and sub-segment of the market are explained below:

By Type:

• Extracorporeal Shock Wave Lithotripsy Devices
• Intracorporeal Lithotripsy Devices

By Application:

• Kidney Stones
• Ureteral Stones
• Pancreatic Stones
• Bile Duct Stones

By End-use:

• Hospitals
• Ambulatory Surgical Centers
• Others

By Region:

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC
• Latin America
• Brazil
• Mexico
• RoLA
• Middle East & Africa
• Saudi Arabia
• South Africa
• RoMEA

Years considered for the study are as follows:

• Historical year - 2022
• Base year - 2023
• Forecast period - 2024 to 2032

Key Takeaways:

• Market Estimates & Forecast for 10 years from 2022 to 2032.
• Annualized revenues and regional level analysis for each market segment.
• Detailed analysis of geographical landscape with Country level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approach.
• Analysis of competitive structure of the market.
• Demand side and supply side analysis of the market.